Novum is a Contract Research Organization (CRO) that provides research services to the worldwide pharmaceutical industry. For over 40 years, Novum has been considered one of the world’s leaders in the conduct of clinical trials. Novum has completed over 3,000 studies for more than 300 pharmaceutical companies.
Criteria:* Naturally or surgically postmenopausal female, with or without an intact uterus, aged 45-65 years
* ≥ 6 months and < 12 months absence of menstruation with serum FSH levels > 40 mIU/mL at screening; or At least 6 weeks postsurgical bilateral oophorectomy with or without hysterectomy
* A body weight ≤ 198lbs and a Body Mass Index (BMI) of 18.5-32.0
* Able to pass a drug screen including marijuana
* No use of Tobacco or Nicotine products within 30 days of the study dosing